Cyclacel Pharmaceuticals, Inc. Earnings Per Share, Basic in USD/shares from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2010 to Q3 2025.
  • Cyclacel Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -1.31 USD/shares, a 97% increase year-over-year.
  • Cyclacel Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was 213 USD/shares.
  • Cyclacel Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2024 was -2.09 USD/shares, a 92.2% increase from 2023.
  • Cyclacel Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -26.8 USD/shares, a 1308% decline from 2022.
  • Cyclacel Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -1.9 USD/shares, a 9.09% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Cyclacel Pharmaceuticals, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $213 -$1 +$42.50 +97% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $171 -$1 +$171 +99.4% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $0 $0 +$2.27 Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 -$2 $216 Oct 1, 2024 Dec 31, 2024 10-K 2025-04-02
Q3 2024 -$44 Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 -$172 -$172 -39032% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 -$2 -$2 -383% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q2 2023 -$1 $0 +$0.02 +4.35% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$1 $0 $0 -11.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$1 -$1 $0 -15.4% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-08
Q3 2022 -$1 $0 +$0.09 +17.6% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$1 $0 +$0.10 +17.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$2 $0 +$0.08 +16% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$2 -$1 Oct 1, 2021 Dec 31, 2021 10-K/A 2023-11-29
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-K/A 2023-11-29
Q2 2021 -$1 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$1 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q2 2014 $0 $0 -320% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-12
Q2 2013 $0.10 +$0.55 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q2 2012 $0 $0 -463% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q3 2011 $0 +$0.04 +36.4% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $0 +$0.10 +55.6% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-12
Q3 2010 $0 Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $0 Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12

Cyclacel Pharmaceuticals, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$2 +$24.70 +92.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-02
2023 -$27 -$25 -1308% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-02
2022 -$2 +$0.19 +9.09% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-08
2021 -$2 +$1.33 +38.9% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-11-29
2020 -$3 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.